Recruiting patients and retaining their participation in a clinical trial remain the biggest challenges faced by pharmaceutical companies when developing new medicines. For a patient, participation in a clinical trial can be stressful and burdensome, resulting in one in four patients dropping out of a clinical trial prior to completion. With sponsors facing tight-timelines, increased regulatory scrutiny and spiralling budgets the desire to address these challenges has never been more prominent.
Taking a patient-centric approach and making the individual rather than the site the focal point of the study is now a common theme in addressing the challenge. An increasingly common example of this philosophy in practice is the concept of Home Trial Support and Direct To Patient delivery.By relocating the clinical trial to the patient’s home through trained medical personnel and specialised logistics capabilities it minimizes the inconvenience to patients, increasing the possibility they consent to participate in a clinical trial and reduces the possibility they withdraw from the study prior to its completion.
In this, the 3rd in a series of webinars focussed on the benefits of taking a patient-centric approach to pharmaceutical development The Medical Research Network (MRN) and World Courierto discuss the practical aspects of Home Trial Support and Direct to Patient Deliveries. Stuart Reading Vice President of Global Business Development & Marketing at MRN and Dave Spillett Key Account Director at World Courier will share their experiences of setting up and implementing the home care model, taking into account varying international regulation, the criticality of patient confidentiality and risk mitigation.
Join us for the next World Courier and MRN webinar, where we explore how practical knowledge and experience are the keys to successfully improving patient experience and moving medicine forwards.
Stuart Redding,
Vice President of Global Business Development & Marketing
Stuart has over 20 years’ experience in the pharmaceutical industry, beginning his career at American Cyanamid before taking positions at Novo Nordisk, MDS Harris and Chiltern, before joining MRN as one of the founders in 2006.
David Spillett,
Key Account Director
David is a pharmaceutical services professional with over 15 years' experience in the provision of GXP compliant services. He is considered a subject matter expert in the context of Clinical Trial Supplies and is one of the few GMP/GDP specialists whose experience includes the administration of investigational products in a clinical setting. David is currently Key Account Director at World Courier where he is often called upon to assist in solving the supply chain challenges associated with novel therapies. He has previously worked as a Clinical Supplies Lead for Penn Pharma where he managed pharmaceutical development and supply chain projects for a variety of small, medium and large pharmaceutical companies.David holds a post graduate diploma in clinical research gained whilst working as a Research Physiologist at Simbec Research Ltd.
- Understand the practical implications affecting patient recruitment and retention
- Hear about the value of a one stop shop and how quality and compliance are improved and competitive advantage can be gained
- Understand how the practicalities of set up and implementation can make or break a study
- Uncover the impact a patient-centric approach can have on trials and patients
- Clinical Project Managers
- Clinical Development Managers
- Clinical Operations Managers
- Clinical Directors
- Head of Clinical Development
- Head of Clinical Research
- Patient Recruitment Managers
- Patient Recruitment
- Feasibility Managers
- Patient Centricity Leads
- Clinical Supply Leads
- Logistics Managers
